Hyperostosis Cranialis Interna

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Description

Hyperostosis cranialis interna is a bone disorder characterized by endosteal hyperostosis and osteosclerosis of the calvaria and the skull base. The progressive bone overgrowth causes entrapment and dysfunction of cranial nerves I, II, V, VII, and VIII (Waterval et al., 2010).

Genes related to Hyperostosis Cranialis Interna

SLC39A14

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Hyperostosis Cranialis Interna

Hearing impairment
Sensorineural hearing impairment
Optic atrophy
Reduced visual acuity
Proptosis
Facial palsy
Overgrowth
Increased bone mineral density
Tinnitus
Epiphora

And another 8 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Hyperostosis Cranialis Interna Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Dystonia Exome Panel. By Genetic Services Laboratory University of Chicago (United States). BCS1L, SCN8A, SCP2, SDHA, SGCE, SLC16A2, SLC20A2, SLC2A1, SLC6A3, SLC6A8, SPR, SQSTM1, STXBP1, SUCLA2, SUOX, SURF1, SYNJ1, TAF1, TBCD, TH , (...) View the complete list with 150 more genes Panel complete gene list BCS1L, SCN8A, SCP2, SDHA, SGCE, SLC16A2, SLC20A2, SLC2A1, SLC6A3, SLC6A8, SPR, SQSTM1, STXBP1, SUCLA2, SUOX, SURF1, SYNJ1, TAF1, TBCD, TH, TIMM8A, NKX2-1, TPI1, TREX1, XK, XPR1, VPS35, FBXO7, ANO3, HTRA2, NPC2, PINK1, MICU1, DNAJC6, CBS, LRPPRC, BSCL2, KMT2B, PANK2, NDUFAF5, SAMHD1, APTX, DNAJC5, SLC19A3, PARK7, BCAP31, MCEE, COQ8A, MLC1, TPK1, ACY1, ARX, RNASEH2A, MMAA, IFIH1, VPS13A, MMAB, MECR, AARS, L2HGDH, TPP1, CLN3, CLN5, CLN6, TUBB4A, CLN8, THAP1, SLC39A14, AARS2, HACE1, SERAC1, FA2H, PDHX, COL4A1, ADAR, COX10, COX15, CP, UBA5, ADCY5, NDUFA12, RNASEH2C, TACO1, CSF1R, MMADHC, CTSD, CTSF, SLC30A10, C19orf12, VAC14, RNASEH2B, KCTD17, DCAF17, TTC19, CYP27A1, HEPACAM, FOXRED1, COX20, DDC, NDUFAF2, MFSD8, NDUFAF6, DNAJC12, WDR45, DLAT, TBC1D24, EARS2, TOR1AIP1, LIPT1, UQCRQ, COASY, ATP13A2, PRRT2, CLPB, TOR1A, AFG3L2, ECHS1, SDHAF1, FOXG1, FTL, FUCA1, GAMT, GCDH, GCH1, GLB1, GM2A, GNAL, GNAO1, GNB1, ALS2, GRN, HEXA, HIVEP2, HPCA, HPRT1, MDH2, MECP2, ARSA, MMUT, NDUFA10, NDUFA2, NDUFA9, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS7, NDUFS8, NDUFV1, NPC1, ATM, ATP1A2, ATP1A3, NUP62, PRKN, ATP7B, PDGFB, PDGFRB, PDHA1, AUH, PLA2G6, PLP1, PNKD, PNKP, POLG, PPT1, PRKRA, PSEN1, PTS, QDPR Specificity 1 % Genes 100 %
Parkinson Disease and Parkinsonism Sequencing Panel with CNV Detection. By PreventionGenetics PreventionGenetics (United States). SLC20A2, SLC6A3, SNCA, SNCB, SPG11, SPR, SYNJ1, TAF1, TARDBP, TWNK, TH, GIGYF2, UCHL1, XPR1, VPS35, FBXO7, HTRA2, PINK1, DNAJC6, CHCHD10 , (...) View the complete list with 48 more genes Panel complete gene list SLC20A2, SLC6A3, SNCA, SNCB, SPG11, SPR, SYNJ1, TAF1, TARDBP, TWNK, TH, GIGYF2, UCHL1, XPR1, VPS35, FBXO7, HTRA2, PINK1, DNAJC6, CHCHD10, PARK7, RAB39B, ATP6AP2, LRRK2, LYST, CLN3, SLC39A14, CHCHD2, CP, VPS13C, CSF1R, SLC30A10, C19orf12, DCAF17, ADORA1, DCTN1, DNAJC12, WDR45, DNM1L, TENM4, ATP13A2, DNAJC13, EIF4G1, PTRHD1, FTL, GBA, GCH1, GRN, DNAJB2, APP, KIF5A, MAPT, ATP1A3, PRKN, PDE10A, PDE8B, PDGFB, PDGFRB, PLA2G6, PODXL, POLG, POLG2, PRKAR1B, PRKRA, PRNP, PSEN1, PSEN2, RAB29 Specificity 2 % Genes 100 %
Dystonia. By Asper Biogene Asper Biogene LLC (Estonia). SGCE, SLC25A1, SLC2A1, SLC6A3, SPR, TAF1, TBCE, TH, TIMM8A, ACTB, CACNA1B, ANO3, PANK2, TUBB4A, THAP1, SLC39A14, COL6A3, ADCY5, SLC30A10, KCTD17 , (...) View the complete list with 18 more genes Panel complete gene list SGCE, SLC25A1, SLC2A1, SLC6A3, SPR, TAF1, TBCE, TH, TIMM8A, ACTB, CACNA1B, ANO3, PANK2, TUBB4A, THAP1, SLC39A14, COL6A3, ADCY5, SLC30A10, KCTD17, DRD2, PRRT2, TOR1A, GCDH, GCH1, GNAL, GNAO1, HPCA, KCNMA1, ARSA, ATM, ATP1A3, PRKN, ATP7B, PLA2G6, PNKD, PRKRA, RELN Specificity 3 % Genes 100 %
Neurodegeneration with Brain Iron Accumulation (NBIA) Panel, Sequencing. By NBIA Testing Center Oregon Health & Science University (United States). SCP2, SQSTM1, KMT2B, PANK2, TRIM32, VPS13A, MECR, SLC39A14, FA2H, CP, C19orf12, DCAF17, WDR45, COASY, ATP13A2, FTL, FUCA1, KIF1A, PLA2G6 Specificity 6 % Genes 100 %
Neurodegeneration with Brain Iron Accumulation (NBIA) Panel, Sequencing and Deletion/Duplication. By NBIA Testing Center Oregon Health & Science University (United States). SCP2, SQSTM1, KMT2B, PANK2, TRIM32, VPS13A, MECR, SLC39A14, FA2H, CP, C19orf12, DCAF17, WDR45, COASY, ATP13A2, FTL, FUCA1, KIF1A, PLA2G6 Specificity 6 % Genes 100 %
Neurodegeneration with Brain Iron Accumulation (NBIA) Panel, Deletion/Duplication. By NBIA Testing Center Oregon Health & Science University (United States). SQSTM1, PANK2, TRIM32, VPS13A, SLC39A14, FA2H, CP, C19orf12, DCAF17, WDR45, COASY, ATP13A2, FTL, FUCA1, KIF1A, PLA2G6 Specificity 7 % Genes 100 %
SLC39A14. By Fulgent Genetics Fulgent Genetics (United States). SLC39A14 Specificity 100 % Genes 100 %
SLC39A14-Related Early-Onset Dystonia-Parkinsonism: gene sequencing. By CEN4GEN Institute for Genomics and Molecular Diagnostics (Canada). SLC39A14 Specificity 100 % Genes 100 %

You can get up to 0 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM ORPHANET MESH Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like RENAL CELL CARCINOMA, NONPAPILLARY; RCC PIERPONT SYNDROME; PRPTS MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD ABETA AMYLOIDOSIS, ARCTIC TYPE MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C